Literature DB >> 26120135

Diagnostic inertia in obesity and the impact on cardiovascular risk in primary care: a cross-sectional study.

Damian R J Martínez-St John1, Antonio Palazón-Bru2, Vicente F Gil-Guillén2, Armina Sepehri1, Felipe Navarro-Cremades1, Dolores Ramírez-Prado3, Domingo Orozco-Beltrán1, Concepción Carratalá-Munuera1, Ernesto Cortés4, María M Rizo-Baeza5.   

Abstract

BACKGROUND: Prevalence of diagnostic inertia (DI), defined as a failure to diagnose disease, has not been analysed in patients with obesity. AIM: To quantify DI for cardiovascular risk factors (CVRF) in patients with obesity, and determine its association with the cardiovascular risk score. DESIGN AND
SETTING: Cross-sectional study of people ≥40 years attending a preventive programme in primary healthcare centres in Spain in 2003-2004.
METHOD: All patients with obesity attending during the first 6 months of the preventive programme were analysed. Participants had to be free of CVD (myocardial ischaemia or stroke) and aged 40-65 years; the criteria used to measure SCORE (Systematic COronary Risk Evaluation). Three subgroups of patients with obesity with no personal history of CVRF but with poor control of risk factors were established. Outcome variable was DI, defined as poor control of risk factors and no action taken by the physician. Secondary variables were diabetes, fasting blood glucose (FBG), body mass index (BMI), and SCORE. Adjusted odds ratios (OR) was determined using multivariate logistic regression models.
RESULTS: Of 8687 patients with obesity in the programme, 6230 fulfilled SCORE criteria. Prevalence of DI in the three subgroups was: hypertension, 1275/1816 (70.2%) patients affected (95% CI = 68.1 to 72.3%); diabetes, 335/359 (93.3%) patients affected (95% CI = 90.7 to 95.9%); dyslipidaemia subgroup, 1796/3341 (53.8%) patients affected (95% CI = 52.1 to 55.4%. Factors associated with DI for each subgroup were: for hypertension, absence of diabetes, higher BMI, and greater cardiovascular risk; for dyslipidaemia, diabetes, higher BMI, and greater cardiovascular risk (SCORE); and for diabetes, lower FBG levels, lower BMI, and greater cardiovascular risk.
CONCLUSION: This study quantified DI in patients with obesity and determined that it was associated with a greater cardiovascular risk. © British Journal of General Practice 2015.

Entities:  

Keywords:  diabetes mellitus; dyslipidaemias; hypertension; inertia; obesity; physician’s practice patterns; primary health care

Mesh:

Year:  2015        PMID: 26120135      PMCID: PMC4484946          DOI: 10.3399/bjgp15X685669

Source DB:  PubMed          Journal:  Br J Gen Pract        ISSN: 0960-1643            Impact factor:   5.386


  17 in total

1.  Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report.

Authors: 
Journal:  Circulation       Date:  2002-12-17       Impact factor: 29.690

2.  Screening for type 2 diabetes.

Authors: 
Journal:  Diabetes Care       Date:  2003-01       Impact factor: 19.112

Review 3.  Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults--The Evidence Report. National Institutes of Health.

Authors: 
Journal:  Obes Res       Date:  1998-09

4.  Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  Hypertension       Date:  2003-12-01       Impact factor: 10.190

5.  Clinical inertia in diagnosis and treatment of hypertension in primary care: quantification and associated factors.

Authors:  Vicente Gil-Guillén; Domingo Orozco-Beltrán; Rafael Peset Pérez; Jose Luis Alfonso; Josep Redón; Salvador Pertusa-Martínez; Jorge Navarro; Luis Cea-Calvo; Fernando Quirce-Andrés; Jaime Merino-Sánchez; Concepción Carratalá; José María Martín-Moreno
Journal:  Blood Press       Date:  2010-02       Impact factor: 2.835

6.  Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project.

Authors:  R M Conroy; K Pyörälä; A P Fitzgerald; S Sans; A Menotti; G De Backer; D De Bacquer; P Ducimetière; P Jousilahti; U Keil; I Njølstad; R G Oganov; T Thomsen; H Tunstall-Pedoe; A Tverdal; H Wedel; P Whincup; L Wilhelmsen; I M Graham
Journal:  Eur Heart J       Date:  2003-06       Impact factor: 29.983

7.  European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice.

Authors:  Guy De Backer; Ettore Ambrosioni; Knut Borch-Johnsen; Carlos Brotons; Renata Cifkova; Jean Dallongeville; Shah Ebrahim; Ole Faergeman; Ian Graham; Giuseppe Mancia; Volkert Manger Cats; Kristina Orth-Gomér; Joep Perk; Kalevi Pyörälä; José L Rodicio; Susana Sans; Vedat Sansoy; Udo Sechtem; Sigmund Silber; Troels Thomsen; David Wood
Journal:  Eur Heart J       Date:  2003-09       Impact factor: 29.983

8.  British Hypertension Society guidelines for hypertension management 2004 (BHS-IV): summary.

Authors:  Bryan Williams; Neil R Poulter; Morris J Brown; Mark Davis; Gordon T McInnes; John F Potter; Peter S Sever; Simon McG Thom
Journal:  BMJ       Date:  2004-03-13

9.  Hypertension management: the care gap between clinical guidelines and clinical practice.

Authors:  Susan E Andrade; Jerry H Gurwitz; Terry S Field; Michael Kelleher; Sumit R Majumdar; George Reed; Robert Black
Journal:  Am J Manag Care       Date:  2004-07       Impact factor: 2.229

Review 10.  Factors associated with clinical inertia: an integrative review.

Authors:  Isabelle Aujoulat; Patricia Jacquemin; Ernst Rietzschel; André Scheen; Patrick Tréfois; Johan Wens; Elisabeth Darras; Michel P Hermans
Journal:  Adv Med Educ Pract       Date:  2014-05-08
View more
  2 in total

Review 1.  Levels of detection of hypertension in primary medical care and interventions to improve detection: a systematic review of the evidence since 2000.

Authors:  Richard Baker; Andrew Wilson; Keith Nockels; Shona Agarwal; Priya Modi; John Bankart
Journal:  BMJ Open       Date:  2018-03-22       Impact factor: 2.692

2.  Construction, internal validation and implementation in a mobile application of a scoring system to predict nonadherence to proton pump inhibitors.

Authors:  Emma Mares-García; Antonio Palazón-Bru; David Manuel Folgado-de la Rosa; Avelino Pereira-Expósito; Álvaro Martínez-Martín; Ernesto Cortés-Castell; Vicente Francisco Gil-Guillén
Journal:  PeerJ       Date:  2017-06-30       Impact factor: 2.984

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.